Amy Moore Shared New Paper Linking Obesity, Diabetes and Early-onset Colorectal Cancer
Amy Moore, Director of Patient Engagement and Advocacy at Summit Therapeutics, shared a post by Cancer Grand Challenges on LinkedIn, adding:
“New paper from Cancer Grand Challenges teams, including Marcus Goncalves from our Team CANCAN, exploring the link between obesity, diabetes and early-onset colorectal cancer.”
Quoting Cancer Grand Challenges‘s post:
“New in Nature Reviews Endocrinology: Andrew Chan and Yin Cao of Cancer Grand Challenges team PROSPECT, Marcus Goncalves of team CANCAN and co-authors review the evidence for the relationship between obesity, diabetes and the striking rise in early onset colorectal cancer.
The authors also highlight the role of multidisciplinary global team science in understanding and reversing the causes of early onset colorectal cancer.
Title: Early-onset colorectal cancer as an emerging disease of metabolic dysregulation
Authors: Mengxi Du, David A. Drew, Marcus D. Goncalves, Yin Cao, Andrew T. Chan
More posts featuring Amy Moore on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023